跳至主要内容
临床试验/NCT05466721
NCT05466721已完成不适用

HydrustomaC3 - Randomized Clinical Trial to Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients

Hydrumedical12 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2022年6月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Hydrumedical
入组人数
45
试验地点
12
主要终点
Adverse effects

研究概览

简要总结

The surgical ostomy process happens when it is necessary to open an organ (such as the intestine) in order to maintain a communication channel with the external environment. The need for ostomy surgery can happen as a result of illness, genetic factors, or trauma. Despite the extensive improvements in colorectal surgery, in case there is a need for total or partial extraction and exteriorization of the large intestine (colostomy), it is often necessary to perform a stoma that connects the end of the preserved intestine to the skin, in which cases it is necessary to place a a colostomy bag for stool collection. Thus, there is a substantial number of patients who need to live with a permanent abdominal stoma that significantly affects their quality of life, implying significant changes, both physical and social. It will then be necessary for patients to adjust their daily routines in order to deal with stoma care.

The primary objective of this study is to evaluate the Hydrustoma C3 medical devices (plate C3, capsule C3, night bag C3) in terms of its efficacy and safety as colostomy devices. It is also a primary objective of this study to compare the health-related quality of life in patients with colostomy when using a control and Hydrustoma C3 devices.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent;
  • Male and Female patients;
  • Adult aged ≥ 18;
  • Descending and sigmoid colostomy created more than 3 months previously to the beginning of the study;
  • Having formed stool and using a flat ostomy appliance;
  • Able to understand the study procedures and fill questionaries;
  • Able to apply and remove the ostomy device autonomously.

排除标准

  • Repeated experiences of leakage with the usual ostomy device,
  • Chronically liquid stools,
  • Peristomal skin disorders,
  • Known allergic reactions to components of the device,
  • Receiving chemotherapy, radiation therapy or steroids in the previous month

结局指标

主要结局

Adverse effects

时间窗: 14 days

Safety evaluations will be done by monitoring adverse events.

Efficacy of the device (journal of capsule/bag changes)

时间窗: 14 days

Efficacy will be accessed by asking patients to record on a journal/diary, for each capsule/bag change, what was the reason for the change, and the occurrence and level of leakage.

Quality of life of the participant (Stoma Quality of Life questionnaire)

时间窗: 14 days

In order to compare stoma related quality of life in patients with colostomy when using a control device and the Hydrustoma C3 devices the Stoma Quality of Life questionnaire will be used. This questionnaire is composed of 20 questions. Example of question "I worry that the bag detaches.". All questions must be answered on a scale of 1 to 4, being 1 always and 4 never.

Safety of the device (Discolouration, Erosion, Tissue overgrowth score)

时间窗: 14 days

Safety evaluations will be done by monitoring the peristomal skin using the validated Ostomy Skin tool (DET score). The DET Score is calculated by examining the peristomal skin and evaluate the skin based on the descriptions in each of the 3 domains, discolouration (D), erosion (E) and tissue overgrowth (T); and assessing the size of the area affected in each of the 3 domains. The total score is (maximum 15) calculated by adding all of the subscores from each domain together.

次要结局

  • Satisfaction of the participant (questionnaire)(14 days)

研究者

发起方
Hydrumedical
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验